1.Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations[J]. Am J Respir Crit Care Med. 2016; 193(3): 259-272.
2.Singer M, Deutschman C S, Seymour C W, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. The Journal of the American Medical Association. 2016; 315(8):775-787.
3.Sawyer R G, Claridge J A, Nathens A B, et al. Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection [J]. New England Journal of Medicine. 2015; 372(21):1996-2005.
4.Sartelli M, Catena F, Abu-Zidan FM, et al. Management of intra-abdominal infections: Recommendations by the WSES 2016 consensus conference [J]. World Journal of Emergency Surgery. 2017; 12:22.
5.Rhodes A, Evans L E, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock [J]. Critical Care Medicine. 2017;45(3):486-552.
6.Levy M M , Evans L E , Rhodes A . The Surviving Sepsis Campaign Bundle: 2018 update [J]. Intensive Care Medicine. 2018; 44(6):925-928.
7.Fraunberger P , Wang Y , Holler E , et al. Prognostic value of interleukin 6, procalcitonin, and c-reactive protein levels in intensive care unit patients during first increase of fever [J]. Shock. 2006;26(1):10-12.
8.Yanaral T U , Idin K , Uzman S , et al. The prognostic value of procalcitonin and C-reactive protein in critically ill patients A comparison with APACHE II and SOFA scores[C]// The European Anaesthesiology Congress. 2010.
9.Tanriverdi H, Tor, MügeMeltem, Kart L , et al. Prognostic value of serum procalcitonin and C-reactive protein levels in critically ill patients who developed ventilator-associated pneumonia [J]. Annals of Thoracic Medicine. 2015; 10(2):137-142.
10.Ríos-Toro Juan-Jesús, Márquez-Coello Mercedes, García-álvarez José-María, et al. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock [J]. PLOS ONE. 2017;12(4):e0175254-.
11.Ryoo S M, Lee J B, Lee Y S, et al. Lactate Level Versus Lactate Clearance for Predicting Mortality in Patients With Septic Shock Defined by Sepsis-3 [J]. Critical Care Medicine. 2018;46(6):e489-e495.
12.Herrán-Monge, Rubén, Muriel-Bombín, Arturo, García-García, Marta M, et al. Epidemiology and Changes in Mortality of Sepsis After the Implementation of Surviving Sepsis Campaign Guidelines [J]. Journal of Intensive Care Medicine. 2019; 34(9):740-750.
13.Organization W H. Obesity: preventing and managing the global epidemic : report of a WHO consultation on obesity[J]. Geneva World Health Organization. 2000;894(1):18-30.
14.Trivedi V, Bavishi C, Jean R. Impact of obesity on sepsis mortality: A systematic review [J]. Journal of Critical Care. 2015; 30(3):518-524.
15.Wang S, Liu X, Chen Q, et al. The role of increased body mass index in outcomes of sepsis: a systematic review and meta-analysis [J]. BMC Anesthesiology. 2017; 17(1):118.
16.Matthaios P O, Diamanto A, Anastasia Z, et al. The Role of Obesity in Sepsis Outcome among Critically Ill Patients: A Retrospective Cohort Analysis [J]. BioMed Research International. 2016;2016:5941279.
17.isitsak C, Lee J G H, Boyd J H, et al. Increased Ratio of Visceral to Subcutaneous Adipose Tissue in Septic Patients Is Associated With Adverse Outcome [J]. Critical Care Medicine. 2016;44(11):1966-1973.
18.Malmir J , Bolvardi E , Afzal Aghaee M. Serum lactate is a useful predictor of death in severe sepsis and septic shock [J]. Reviews in Clinical Medicine. 2014;1(3):97-104.
19.Lokhandwala S, Andersen L W, Nair S, et al. Absolute lactate value versus relative reduction as a predictor of mortality in severe sepsis and septic shock [J]. Journal of critical care. 2016; 37:179-184.
20.Siddiqui I, Jafri L, Abbas Q, et al. Relationship of serum procalcitonin, c-reactive protein, and lactic acid to organ failure and outcome in critically ill pediatric population [J]. Indian Journal of Critical Care Medicine. 2018;22(2):91-95.
21.Ho K M. Combining Sequential Organ Failure Assessment (SOFA) Score with Acute Physiology and Chronic Health Evaluation (APACHE) II Score to Predict Hospital Mortality of Critically Ill Patients [J]. Anaesthesia and intensive care. 2007; 35(4):515-521.
22.Raith E P, Udy A A, Bailey M, et al. Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit [J]. JAMA. 2017; 317(3):290-300.
23.Probst L, Schalk E, Liebregts T, et al. Prognostic accuracy of SOFA, qSOFA and SIRS criteria in hematological cancer patients: a retrospective multicenter study [J]. Journal of Intensive Care. 2019; 7:41.
24.Liu X, Shen Y, Li Z. et al. Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study [J]. BMC Anesthesiol. 2015;16(1):46
25.Giamarellos-Bourboulis E J , Norrby-Teglund A , Mylona V , et al. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor [J]. Critical Care. 2012;16(4):R149.
26.Vincent J L , Opal S M , Marshall J C . Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions [J]. Critical care medicine. 2010; 38(1):283-287.